Werner Beadle

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Kyverna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get KYTX alerts

About Werner Beadle

Werner Beadle is recorded as CEO at Kyverna Therapeutics, Inc. (KYTX). Werner Beadle has spoken on 1 investor event across 1 company, most recently for Kyverna Therapeutics, Inc. on September 14, 2026. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyverna Therapeutics, Inc. includes Warner Biddle (CEO and Board Member), Christi Shaw (Chairman and Board Member), Greg Martini (CFO) and 7 others.

Werner Beadle on recent calls

“If you have any questions, please reach out to your Morgan Stanley sales representative.”

CEO, Morgan Stanley 24th Annual Global Healthcare Conference · September 14, 2026

Affiliation history

Kyverna Therapeutics, Inc. (KYTX)
CEO

Transcript header (unverified)

Current

Company network

Kyverna Therapeutics, Inc.

KYTX

Current role

Biotechnology · Healthcare

CEO

1 appearance Latest appearance 2026-09-14

View calls and events

Leadership on record at Kyverna Therapeutics, Inc.

Warner Biddle CEO, Board Member
Christi Shaw Chairman, Board Member
Greg Martini CFO
Gregory Martini CFO, Chief Accounting Officer
Marc Grasso CFO
Marc Grasso, M.D. CFO
Mayo Pujols CTO
Andrew Miller Board Member
Andrew Miller, Ph.D. Board Member
Beth Seidenberg Board Member

Recent activity

Conference Morgan Stanley 24th Annual Global Healthcare Conference Kyverna Therapeutics, Inc. (KYTX)
2026-09-14